openPR Logo
Press release

Viral Inactivation Market worth $2,541.74 million by 2030, growing at a CAGR of 14.60% - Exclusive Report by 360iResearch

10-25-2023 12:48 PM CET | Health & Medicine

Press release from: 360iResearch

Viral Inactivation Market | 360iResearch

Viral Inactivation Market | 360iResearch

The "Viral Inactivation Market by Product (Kits & Reagents, Services, Viral Inactivation Systems & Accessories), Method (Pasteurization, Solvent Detergent Method), Application, End User - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/viral-inactivation?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Market Segmentation & Coverage:

This research report categorizes the Viral Inactivation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Kits & Reagents, Services, and Viral Inactivation Systems & Accessories. The Kits & Reagents is projected to witness significant market share during forecast period.

Based on Method, market is studied across Pasteurization and Solvent Detergent Method. The Pasteurization is projected to witness significant market share during forecast period.

Based on Application, market is studied across Blood & Blood Product, Cellular & Gene Therapy Product, Stem Cell Product, Tissues & Tissue Product, and Vaccines & Therapeutic. The Tissues & Tissue Product is projected to witness significant market share during forecast period.

Based on End User, market is studied across Academic Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Contract Research Organizations is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Viral Inactivation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Viral Inactivation Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Viral Inactivation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Cytiva by Danaher Corporation, Eurofins Scientific (Ireland) Limited, HiMedia Laboratories, LLC, Lonza Group Ltd., Merck KGaA, Parker Hannifin Corporation, PromoCell GmbH, Rad Source Technologies, Inc., Sartorius AG, Thermo Fisher Scientific Inc, and WuXi AppTec Co., Ltd..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Viral Inactivation Market, by Product
7. Viral Inactivation Market, by Method
8. Viral Inactivation Market, by Application
9. Viral Inactivation Market, by End User
10. Americas Viral Inactivation Market
11. Asia-Pacific Viral Inactivation Market
12. Europe, Middle East & Africa Viral Inactivation Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Viral Inactivation Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Viral Inactivation Market?
3. What is the competitive strategic window for opportunities in the Viral Inactivation Market?
4. What are the technology trends and regulatory frameworks in the Viral Inactivation Market?
5. What is the market share of the leading vendors in the Viral Inactivation Market?
6. What modes and strategic moves are considered suitable for entering the Viral Inactivation Market?

Read More @ https://www.360iresearch.com/library/intelligence/viral-inactivation?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viral Inactivation Market worth $2,541.74 million by 2030, growing at a CAGR of 14.60% - Exclusive Report by 360iResearch here

News-ID: 3262364 • Views:

More Releases from 360iResearch

Cognitive Systems Market worth $78.39 billion by 2030, growing at a CAGR of 9.39% - Exclusive Report by 360iResearch
Cognitive Systems Market worth $78.39 billion by 2030, growing at a CAGR of 9.39 …
The "Cognitive Systems Market by Components (Services, Software), Applications (BFSI, Healthcare, IT & Telecommunications) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/cognitive-systems?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Rapid Growth in Cognitive Systems Market Driven by Technological and Regulatory Support" The cognitive systems market is experiencing significant growth fueled by increasing product demand, supportive regulatory policies, and an expanding array of end-user applications. Businesses across various sectors, including healthcare,
DNA Repair Drugs Market worth $13.97 billion by 2030, growing at a CAGR of 7.20% - Exclusive Report by 360iResearch
DNA Repair Drugs Market worth $13.97 billion by 2030, growing at a CAGR of 7.20% …
The "DNA Repair Drugs Market by Drug Type (Alkylating Agents, Poly ADP Ribose Polymerase Inhibitors), Form (Capsules, Injectables, Tablets), Mechanism of Action, Application, Distribution Channel - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/dna-repair-drugs?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Drivers of Growth in the DNA Repair Drugs Market: Precision Medicine, Regulatory Support, and Increased Demand" The market for DNA repair drugs is experiencing significant growth, driven by a confluence
Chia Seeds Market worth $685.16 million by 2030, growing at a CAGR of 8.43% - Exclusive Report by 360iResearch
Chia Seeds Market worth $685.16 million by 2030, growing at a CAGR of 8.43% - Ex …
The "Chia Seeds Market by Product (Black Chia Seeds, White Chia Seeds), Form (Grounded, Whole), Application, Distribution Channel - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/chia-seeds?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Rising Demand for Chia Seeds Fueled by Health Awareness, Regulatory Support, and E-commerce Growth" Chia seeds are witnessing a surge in popularity driven by rising consumer awareness of their substantial health benefits, including being rich in omega-3
Chestnuts Market worth $3.94 billion by 2030, growing at a CAGR of 4.39% - Exclusive Report by 360iResearch
Chestnuts Market worth $3.94 billion by 2030, growing at a CAGR of 4.39% - Exclu …
The "Chestnuts Market by Type (American Chestnuts, Chinese Chestnuts, European Chestnuts), Forms (Dried, Fresh, Frozen), Application, Distribution Channel - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/chestnuts?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Global Surge in Chestnut Demand Driven by Health Trends and Strategic Market Developments" The rising consumer demand for nutritious foods is boosting the popularity of chestnuts, known for their rich content of vitamins, minerals, and antioxidants. Growing

All 5 Releases


More Releases for Viral

Viral Inactivation Market Growing Demand of Kits and Reagents Viral Inactivation …
According to Precision Business Insights (PBI), the latest report, the Viral Inactivation market is expected to be worth USD 2.1 billion in 2022, growing at a 12.8% CAGR from 2022 to 2028. The primary driver of the expansion of the global Viral Inactivation market are speedy growth in pharmaceutical and biotechnology industries and strong inclination of R&D investments in life sciences industry. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/viral-inactivation-market/ Kits &
Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry …
Anti-viral drug therapy market comprises of sales of branded & generic anti-viral drugs and related services by entities that manufacture the branded or generic anti-viral drugs for treating microbial infections. Anti-viral drug therapy industry includes several establishments that manufacture anti-viral drugs, which are used to treat diseases caused by viral infections. Examples of antiviral drugs include cidofovir, amantadine, zanamivir, idoxuridine, famiciclovir, tenofovir, adefovir and ribavirin. According to study, “Anti-Viral Drug Therapy
Viral Antigens Market to Reap Excessive Revenues by 2028(Based on product type, …
Antigens are commonly referred to as substances that are capable of triggering an immune response in a host by activating the lymphocytes or initiating antibody production against infections. Depending upon the fact that they either enter the human body or originate within the body, viral antigens are classified as foreign or self-antigens respectively. Among these, self-antigens comprise mutated or overexpressed proteins. However, foreign antigens are likely to include bacteria, parasites,
Viral Vector and Plasmid DNA Manufacturing Market - Increase In Awareness Regard …
The Viral Vector and Plasmid DNA Manufacturing Market is expected to reach $ 1,090 million in 2023, growing at an annual average rate of 22.6% from 2017 to 2023. North America was the largest contributor to the viral vector and plasmid DNA markets in 2016. However, the Asia Pacific region is expected to have the highest growth rate during the forecast period. Gene therapy has included tools such as viral vectors
Viral Vaccines Market : Challenges and Opportunities Against Viral Diseases
Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agent
Global Viral Molecular Diagnostics Market
The Viral Molecular Diagnostics Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps in